Genome Editing in Patient iPSCs Corrects the Most Prevalent USH2A Mutations and Reveals Intriguing Mutant mRNA Expression Profiles

RT @ESC_iPSC_News: Scientists explore a CRISPR/Cas9-mediated strategy for USH2A mutation correction as a potential treatment for Usher synd…

RT @ESC_iPSC_News: Scientists explore a CRISPR/Cas9-mediated strategy for USH2A mutation correction as a potential treatment for Usher synd…

Scientists explore a CRISPR/Cas9-mediated strategy for USH2A mutation correction as a potential treatment for Usher syndrome and autosomal recessive retinitis pigmentosa patients. https://t.co/Q3QTZ8FkIV